论文部分内容阅读
据息,发改委拟放开非处方药、非医保目录等药品价格,实行市场调节,由企业自主定价。业内称,此举成行,将有利于让消费者买到质优价廉的非处方药,但要防范企业借机违规乱涨价。消息称,放开药品价格的范围包括医保目录外的中国物质专利药品、医保目录外血液制品、零售药店出售的医保目录非处方药品、医保目录中药品通用名下不报销的药品剂型、国家统一收购的计生药具和国家免疫规划疫苗5类品种。前述品种取消政府定价,由生产经营企业根据市场供给自主定价。
According to the information, the NDRC intends to release non-prescription drugs, non-medical insurance catalog and other drug prices, the implementation of market regulation, independent pricing by the enterprise. Industry said the move will help consumers to buy cheap non-prescription drugs, but to prevent illegal business opportunistic price hikes. According to the sources, the scope of drug prices liberalization includes Chinese patent medicines outside the medical insurance catalog, blood products outside the medical insurance catalogs, over-the-counter medicines for medical insurance catalogs sold by retail pharmacies, pharmaceutical dosage forms not reimbursed under the common names in the medical insurance catalogs, Family planning medicines and vaccines five kinds of national immunization programs. The aforesaid varieties cancel the government pricing and are independently priced by the production and operation enterprises according to the market supply.